XML 16 R7.htm IDEA: XBRL DOCUMENT v3.23.2
Consolidated Statements of Cash Flows - USD ($)
$ in Thousands
 6 Months Ended
Jun. 30, 2023
Jun. 30, 2022
Operating Activities    
Net Income Including the Noncontrolling Interests in Subsidiaries $ 144,468 $ 105,355
Adjustments to Reconcile Net Income to Net Cash Provided (Used) by Operating Activities    
Depreciation and Amortization 14,724 14,423
Share-Based Compensation Expense 19,677 18,720
Subsidiary Share-Based Compensation Expense 0 707
(Gain) Loss on Disposal of Assets (401) (737)
Provision (Benefit) for Deferred Income Taxes (1,376) (2,163)
Consolidation/(Deconsolidation) of Other Entities (2,176) (20)
Net Unrealized (Gain) Loss on Investments (5,118) 33,315
Net Sales (Purchases) of Investments—Consolidated Investment Companies (17,843) (43,219)
Other Changes in Assets and Liabilities:    
(Increase) Decrease in Receivables, net (40,636) 10
(Increase) Decrease in Prepaid Expenses and Other Assets 16,982 (3,526)
Increase (Decrease) in Accounts Payable and Accrued Expenses (46,268) (53,008)
Increase (Decrease) in Other Liabilities (5,469) 9,659
Net Cash Provided (Used) by Operating Activities 76,564 79,516
Investing Activities    
Purchases of Investments—Affiliates and Other (11,245) (5,081)
Proceeds from Redemptions of Investments—Affiliates and Other 22,213 8,067
Cash Paid for Property and Equipment (3,722) (2,889)
Net Cash Provided (Used) by Investing Activities 7,246 97
Financing Activities    
Dividends Paid (49,260) (49,659)
Purchases of Treasury Stock (47,915) (204,604)
Distributions to Noncontrolling Interests in Subsidiaries (17,678) (5,524)
Contributions from Noncontrolling Interests in Subsidiaries 32,460 45,654
Cash paid for Business Acquisitions (857) (6,913)
Proceeds from New Borrowings 0 488,300
Payments on Debt 0 (311,650)
Other Financing Activities 0 (2,571)
Net Cash Provided (Used) by Financing Activities (83,250) (46,967)
Effect of Exchange Rates on Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 5,651 (17,717)
Net Increase (Decrease) in Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 6,211 14,929
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Beginning of Period 340,955 238,052
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, End of Period 347,166 252,981
Less: Restricted Cash Recorded in Other Current Assets 4,014 3,978
Less: Restricted Cash and Restricted Cash Equivalents Recorded in Other Long-Term Assets 395 271
Cash and Cash Equivalents $ 342,757 $ 248,732